If you require special assistance to attend this event, please contact CEC at (866) 360-1717.
In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This application-based activity is approved for 1.5 contact hours (.15 CEUs) of continuing pharmacy education credit (UAN 0245-0000-17-003-L01-P).
Participants will be provided with instructions for receiving credit through Creative Educational Concepts’ web portal, CE Spectrum, during the live activity.
Psychiatric and neurologic pharmacists are actively involved in the care of patients with long-standing psychiatric illness, many of whom receive antipsychotic medications for extended periods of time. Trained specialty pharmacists have been shown to assess abnormal movements at a skill level comparable to trained physicians and are ideally positioned to assist in the documentation of AIMS/DISCUS scores for the patient at risk. They also may be a primary provider for treatment decisions or part of the treatment team and can guide optimal medication selection. CPNP attendees will review new data with clinical experts and interact via patient cases to ensure they are current with their assessment techniques and knowledgeable about new treatment options.
Upon completion of this application-based activity, the participant will be able to:
- Outline risk factors for development of tardive dyskinesia in the psychiatric setting.
- Assess new onset or progression of movement symptoms in patients at risk for tardive dyskinesia and differentiate from other diagnoses.
- Identify treatment options for tardive dyskinesia in the psychiatric patient, using evidence-based and emerging therapies with the highest degree of demonstrated efficacy and safety.
- Using real-world cases, explore the role of psychiatric and neurologic pharmacists in the practical assessment of movement disorders, notably TD, and assist with the implementation of treatment protocols to improve patient outcomes.
This activity is designed to meet the educational needs of psychiatric and neurology pharmacists attending the 2017 CPNP Annual Meeting.